• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Origin Therapeutics

Recent news which mentions Origin Therapeutics

Origin Therapeutics Attaches Clairvoyant To Its Portfolio, Fueling Fast Market Strategy For Psilocybin Therapy
July 07, 2022
Tags Contracts Financing Alexander Somjen
From Benzinga
New Psychedelic Investment Opportunity: Look For "ORIG" (Origin Therapeutics) On The CSE Starting June 6
June 02, 2022
Tickers CSE IPOS
Tags Benzinga Psychedelics Alexander Somjen
From Benzinga
Yet Another Company Joins The World Of Psychedelic Retreats, This Time In Canada
May 17, 2022
Tickers SILFF
Tags News Markets Cannabis
From Benzinga
Psyched: Atai Launches 'Salvia Divinorum' Subsidiary, Mindset, Psilera and Wesana's Preclinical Trials, Origin Raises $5M
August 16, 2021
Tickers ATAI AWKNF MSSTF WSNAF
Tags Markets ATAI Penny Stocks
From Benzinga
Origin Therapeutics Will Invest $6.5M In Psychedelics Startups
August 13, 2021
Tags Market News Benzinga psychedelics
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap